Health
Tiny antibody component shows high potency in SARS-CoV-2 animal models – News-Medical.Net
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug–known as Ab8–for potential use as a therapeutic and prophylactic against SARS-CoV-2.
The researchers report today in the journal…
-
Business19 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News18 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business18 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News22 hours agoEverything To Know About Spilt Milk 2025